跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16 条关于
“VelocImmune”
全部
16
临床试验
0
药物
0
机构
0
资讯
16
7个月前
Regeneron Unveils First-in-Class Phase 3 Data for Novel Cat and Birch Allergy Treatments at AAAAI 2026
5个月前
Telix and Regeneron Form $2.1 Billion Strategic Partnership to Develop Next-Generation Radiopharmaceuticals
去年
EMA Approves Dupixent for Eosinophilic Esophagitis in Young Children
去年
Dupixent Shows Positive Phase 3 Results for Chronic Spontaneous Urticaria
2年前
FDA Approves Dupixent as First Treatment for CRSwNP in Adolescents
去年
EMA Approves Dupixent for Eosinophilic Esophagitis in Young Children
去年
Dupixent Approved in EU for Eosinophilic Esophagitis in Young Children
4年前
FDA Extends Review of Regeneron's REGEN-COV for COVID-19 Treatment and Prophylaxis
11个月前
Regeneron Presents New Libtayo Data at ESMO 2025, Showcasing Patient-Centric Every 6-Week Dosing for High-Risk Skin Cancer
7个月前
FDA Grants Priority Review to Garetosmab for Ultra-Rare Bone Disease Fibrodysplasia Ossificans Progressiva
第 1 页,共 2 页
上一页
下一页